10X Genomics Inc - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
TXG Nasdaq 2836 https://www.10xgenomics.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for 10X Genomics Inc

NextGen (NXGN) Riding on the Success of Cloud-Based Solution - Mar 7th, 2023 2:15 pm
We're Hopeful That 10x Genomics (NASDAQ:TXG) Will Use Its Cash Wisely - Mar 2nd, 2023 10:47 am
10x Genomics to Present at the 43rd Annual Cowen Healthcare Conference - Feb 22nd, 2023 9:30 pm
10x Genomics, Inc. (NASDAQ:TXG) Q4 2022 Earnings Call Transcript - Feb 17th, 2023 12:13 am
10x Genomics (TXG) Reports Q4 Loss, Tops Revenue Estimates - Feb 15th, 2023 10:25 pm
10x Genomics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Outlook for 2023 - Feb 15th, 2023 9:05 pm
Earnings Preview: Syneos Health (SYNH) Q4 Earnings Expected to Decline - Feb 9th, 2023 3:01 pm
10x Genomics (TXG) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Feb 8th, 2023 3:00 pm
10x Genomics Demonstrates Breadth, Scale and Leadership at 2023 AGBT General Meeting - Feb 6th, 2023 2:00 pm
3 CRISPR Stocks to Buy Now Or You’ll Be Kicking Yourself Later - Feb 2nd, 2023 5:58 pm
10x Genomics to Report Fourth Quarter and Full Year 2022 Financial Results on February 15, 2023 - Jan 19th, 2023 9:05 pm
3 Medical Info Systems Stocks Braving Industry-wide Headwinds - Jan 17th, 2023 9:10 am
10x Genomics toolkit ‘at the fulcrum of innovation,’ CEO says - Jan 10th, 2023 5:02 pm
10x Genomics to Present at the 41st Annual J.P. Morgan Healthcare Conference - Dec 28th, 2022 9:05 pm
10x Genomics (NASDAQ:TXG) adds US$133m to market cap in the past 7 days, though investors from a year ago are still down 75% - Dec 22nd, 2022 12:03 pm
10x Genomics Commercially Launches Xenium Platform for In Situ Analysis - Dec 8th, 2022 9:05 pm
East Bay startup Infinimmune's secret for building better antibody drugs: You - Dec 6th, 2022 10:42 pm
At US$38.66, Is It Time To Put 10x Genomics, Inc. (NASDAQ:TXG) On Your Watch List? - Dec 1st, 2022 10:28 am
10x Genomics Launches BEAM to Improve and Streamline Antibody and T-Cell Receptor Discovery - Nov 9th, 2022 9:05 pm
10x Genomics Third Quarter 2022 Earnings: Beats Expectations - Nov 9th, 2022 11:14 am